Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

The nuclear danger of iodine

20 May 2015 Comments

It may not be an element you think of as problematic. But, as Mark Foreman explains, iodine causes very complicated problems in nuclear accidents

Flexible, faster formulation

30 April 2015 Comments

The chemical using industries remain central to UK economic recovery, explains Simon Rushworth

Be careful what you wish for

25 March 2015 Comments

Measuring R&D productivity is a thorny issue. Dennis Lendrem urges the pharmaceutical industry to learn from its mistakes.

Setting the record straight

19 February 2015 Comments

Everyone makes mistakes, says François-Xavier Coudert. But in science, everyone has to correct them too.

Target ignorance to tackle resistance

12 February 2015 Comments

Countries like India are bearing the brunt of antibiotic resistance, and education could be a key tool in tackling its spread

Indian science at the crossroads

12 February 2015 Comments

S Umapathy, from the Indian Institute of Science, Bangalore, surveys the Indian scientific landscape

What we mean when we talk about bonds

29 January 2015 Comments

Santiago Alvarez delves into the debates and disagreements that surround one of chemistry's most fundamental concepts

Reflections on the REF

18 December 2014 Comments

Richard Catlow and Graham Hutchings evaluate the state of chemistry research and find it enjoying rude health

Good science, bad science?

13 November 2014 Comments

Paul Leonard is concerned by industry's exclusion from policy panels – it’s the science that matters, not who pays for it

Public health is the bottom line

13 November 2014 Comments

To safeguard society, regulators must be free from the influence of industry interests, says Martin Pigeon

Not all science is created equal

16 October 2014 Comments

John Ioannidis explains why researchers should be curious about the differences between disciplines

An escape plan

2 October 2014 Comments

Karin Bodewits suggests that academia’s chairs might hold more women if they have a clear view of the exit

Carl Djerassi - chemistry and theatre

30 September 2014 Comments

Carl Djerassi explains his move from distinguished chemist to 'intellectual smuggler'

In defence of metrics

20 August 2014 Comments

Are metrics a necessary evil, or can they be a force for good? Anthony Olejniczak sticks up for stats

The energy to fight injustice

23 July 2014 Comments

Giving the world carbon-free energy means putting nuclear energy back on the agenda, says James Hansen

Of atoms and aesthetics

3 July 2014 Comments

From molecular representations to elegant syntheses, Tami Spector considers the ways chemists find beauty in their work

We need to talk about Nagoya

29 May 2014 Comments

Darren Smyth explains why the Nagoya Protocol could become a problem for European research

The wisdom of clouds

8 May 2014 Comments

Kai Kohlhoff discusses the promise and pitfalls of doing science with distributed computing

Strength in numbers

8 April 2014 Comments

For all the value it provides, analytical chemistry doesn’t get the recognition it deserves, say Mark Powell and Steven Lancaster

'No sexuality please, we're scientists'

1 April 2014 Comments

David Smith wonders why gay scientists seem to stay unseen, and asks does it matter?

The future of feedstocks

6 March 2014 Comments

Where will our chemicals come from when the oil wells run dry? Jose Lopez-Sanchez discusses renewable feedstocks

Diplomacy through education

27 February 2014 Comments

Jay Siegel is building the future of China’s Tianjin University by looking to its past – combining the academic cultures of east and west

Peak oil is not a myth

20 February 2014 Comments

Fracking won’t plug the gap in crude oil’s falling figures, says Chris Rhodes. Oil’s exhaustion is inevitable

Arsenic and old waste

23 January 2014 Comments

William Bains worries that scientists are losing their way in the wild frontiers of research

Cut price pills cost more than pennies

19 December 2013 Comments

We can’t afford to let the demand for cheaper medicines force compromises on quality, says Steven Ford